(Q42532114)

1 November 2017

Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort (English)

1 reference

1 November 2017

17

1 reference

1 November 2017

Jennifer R Stark

5

0 references

Francesca Demichelis

Francesca Demichelis

3

0 references

Katja Fall

Katja Fall

4

0 references

Philip W. Kantoff

Philip W Kantoff

12

0 references

Hans-Olov Adami

6

Hans-Olov Adami

1 reference

1 November 2017

1

Lorelei A Mucci

1 reference

1 November 2017

10

Lars Holmberg

1 reference

1 November 2017

15

Meir J Stampfer

1 reference

1 November 2017

2

Yudi Pawitan

1 reference

1 November 2017

14

Sven Perner

1 reference

1 November 2017

8

Ove Andrén

1 reference

1 November 2017

7

Swen-Olof Andersson

1 reference

1 November 2017

16

Jan-Erik Johansson

1 reference

1 November 2017

9

Anna Eisenstein

1 reference

1 November 2017

Wei Huang

11

1 reference

PMCID

2536630

1 November 2017

Robert Kim

13

1 reference

1 November 2017

26 June 2008

1 reference

Cancer Epidemiology, Biomarkers & Prevention

1 November 2017

1 reference

1 November 2017

17

1 reference

1 November 2017

1682-1688

1 reference

1 November 2017

7

1 reference

Prostate-specific antigen levels as a predictor of lethal prostate cancer

1 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

Long-term outcome among men with conservatively treated localised prostate cancer.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

Defining aggressive prostate cancer using a 12-gene model

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

Internet-based Profiler system as integrative framework to support translational research

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

Radical prostatectomy versus watchful waiting in early prostate cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

20-year outcomes following conservative management of clinically localized prostate cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

SAS macros for estimation of the cumulative incidence functions based on a Cox regression model for competing risks survival data

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

Natural history of progression after PSA elevation following radical prostatectomy

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

Evaluating the yield of medical tests

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

Prostate cancer and the Will Rogers phenomenon.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

Determinants of Prostate Cancer Specific Survival Following Radiation Therapy During the Prostate Specific Antigen Era

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

Pretreatment predictors of time to cancer specific death after prostate specific antigen failure

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

Quality of life after radical prostatectomy or watchful waiting.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

Natural History of Early, Localized Prostate Cancer

16 August 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

3 November 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2536630

A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer

1 December 2018

1 reference

12 December 2020

The ratio of prostate chips with cancer:A new measure of tumor extent and its relationship to grade and prognosis

1 reference

12 December 2020

A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis

1 reference

12 December 2020

Determining overdiagnosis by screening with DRE/TRUS or PSA (Florence pilot studies, 1991-1994)

1 reference

12 December 2020

Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy

1 reference

12 December 2020

How Well Does the Gleason Score Predict Prostate Cancer Death? A 20-Year Followup of a Population Based Cohort in Sweden

1 reference

12 December 2020

Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

1 reference

12 December 2020

10.1158/1055-9965.EPI-08-0044

Identifiers

DOI

1 reference

1 November 2017

1 reference

1 November 2017

1 reference

PMCID

2536630